Keyphrases
Antiarrhythmic Drugs
100%
Drug Efficacy
100%
Clinical Practitioners
100%
Atrial Fibrillation
60%
Efficacy Endpoint
60%
Clinical Trials
40%
Clinical Practice
40%
Quality of Life
20%
Heart Failure
20%
Hospitalization
20%
Patient Subgroups
20%
Cardiovascular Mortality
20%
Clinical Efficacy
20%
Drug Management
20%
Hemodynamic Effects
20%
Cardiac Implantable Electronic Device
20%
Total Mortality
20%
Atrial Fibrillation Burden
20%
Cardiovascular Outcomes
20%
First Recurrence
20%
Atrial Fibrillation Recurrence
20%
Frequency-duration
20%
Medicine and Dentistry
Atrial Fibrillation
100%
Antiarrhythmic Agent
100%
Drug Efficacy
100%
Clinical Trial
40%
Cardiovascular System
40%
Recurrent Disease
40%
Quality of Life
20%
Hemodynamic
20%
Congestive Heart Failure
20%
Nursing and Health Professions
Atrial Fibrillation
100%
Antiarrhythmic Agent
100%
Clinical Practice
40%
Recurrent Disease
40%
Quality of Life
20%
Congestive Heart Failure
20%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Antiarrhythmic Agent
100%
Clinical Trial
40%
Recurrent Disease
40%
Congestive Heart Failure
20%